BMI and Cardiovascular Disease Risk Beyond Blood Pressure and Lipids
BMI is associated with cardiovascular disease, but most of the risk is mediated through blood pressure, lipids, and glucose. Central adiposity markers add information BMI misses.
BMI and Cardiovascular Disease Risk Beyond Blood Pressure and Lipids
BMI is associated with cardiovascular disease in observational studies. But a substantial portion of that link is mediated through blood pressure, dyslipidaemia, and dysglycaemia, the very factors clinicians already measure. The central unresolved question for screening protocols is whether BMI provides independent predictive value once those are known. The Emerging Risk Factors Collaboration (2011, Lancet) meta-analysis of 221,934 participants from 58 prospective studies found that BMI, waist circumference, and waist-to-hip ratio did not substantially improve cardiovascular risk prediction once blood pressure, lipids, and diabetes status were in the model. For a person whose blood pressure and lipid profile are already recorded, adding their BMI number changes the risk estimate very little. BMI is a screening signal at population scale, not a cardiovascular diagnosis for an individual. The term bmi cardiovascular disease risk independent describes a relationship that, in the evidence, is largely not independent at all. It is carried by the metabolic pathways that BMI flags but does not directly cause.
What BMI Adds to Cardiovascular Risk Prediction Once Standard Risk Factors Are Measured
Why BMI Adds Almost Nothing After Standard Tests
The 2011 Emerging Risk Factors Collaboration study pooled data from 17 countries. It tested whether adding BMI, waist circumference, or waist-to-hip ratio to a model that already included blood pressure, lipid profile (LDL cholesterol and HDL cholesterol), and diabetes status improved the prediction of coronary heart disease and stroke. The answer was no for all three measures. The hazard ratio for cardiovascular events per one-standard-deviation increase in BMI fell from 1.07 to essentially 1.00 after adjustment for those standard risk factors. Waist-to-hip ratio showed a stronger unadjusted link, hazard ratio 1.32, but that too was largely attenuated after mediation analysis accounted for the intermediate variables.
What This Means For Your Risk Score
If a clinician already has your blood pressure and a standard lipid panel, the BMI number adds almost nothing to the Framingham Risk Score or the pooled cohort equation that estimates your 10-year cardiovascular disease risk. The relationship between BMI and heart disease runs through the mechanisms that raise blood pressure and disturb the lipid profile. It does not travel through a separate, independent pathway. The population-attributable fraction of cardiovascular disease linked to high BMI is large, but it is almost entirely attributable to the downstream effects on blood pressure and lipids. Those are the targets of routine screening.
BMI Coronary Heart Disease Risk: The Mediated Pathway
The Number That Gets Misread
For coronary heart disease, the Global BMI Mortality Collaboration (2016, Lancet) meta-analysis of 10.6 million participants found a hazard ratio of 1.27 per 5 kg/m² increase in BMI. That number is cited as evidence that BMI directly causes coronary heart disease. It does not. The same analysis showed that controlling for blood pressure and circulating lipids substantially reduced the relationship. Each 5 kg/m² rise in BMI is accompanied by an average increase in systolic blood pressure and measurable shifts in LDL cholesterol and HDL cholesterol. Those shifts, not the BMI number itself, are the proximal drivers of coronary heart disease risk.
Do Not Read BMI As A Direct Coronary Diagnosis
A person with a BMI of 31 who has blood pressure of 115/75 and a lipid profile within normal ranges has a different risk profile than a person with the same BMI and elevated blood pressure. BMI flags the population-level correlation. The individual risk requires the direct measurements.
| Outcome | Association Strength Per 5 kg/m² BMI Increase | Remaining Association After Adjustment For Blood Pressure And Lipids |
|---|---|---|
| Coronary heart disease | HR 1.27 (1.23–1.31) | Substantially reduced; near null in mediation analysis |
| Stroke | HR 1.12 (1.07–1.17) | Weaker; largely explained by blood pressure |
| Heart failure | HR 1.41 (1.34–1.47) | Stronger than for CHD; partly independent of blood pressure and lipids |
| All-cause mortality (at BMI nadir 20–25) | J-shaped curve; nadir at 22.5–25.0 | Confounded by reverse causation; Mendelian randomisation suggests more linear causal effect |
Waist Circumference Cardiovascular Risk: What Central Adiposity Adds That BMI Does Not
Why Fat Location Matters More Than Total Mass
BMI misses a critical dimension of risk: where the fat is stored. Visceral adipose tissue, fat stored inside the abdominal cavity around organs, carries a stronger independent link with cardiovascular disease than total body fat. Waist circumference is a tape-measured surrogate for visceral adipose tissue. Waist-to-height ratio scales that measurement to stature, removing the need for sex-specific cut-offs.
Which Thresholds To Use And Why
NICE CG189 (2022), the UK National Institute for Health and Care Excellence guideline, introduced waist-to-height ratio as a central adiposity marker alongside BMI. The threshold is 0.5. A ratio above 0.5 indicates increased cardiometabolic risk regardless of BMI. The NIH/NHLBI waist circumference thresholds from 1998 remain in use in the United States, but they were derived from white populations and misclassify risk in other groups. The International Diabetes Federation's 2006 thresholds for Europid populations are lower: ≥94 cm for men and ≥80 cm for women.
How To Measure Waist Circumference Correctly
Measure waist circumference at the midpoint between the lowest rib and the iliac crest at the end of a normal expiration, using the NICE protocol. A waist-to-height ratio above 0.5 adds predictive power that BMI alone cannot provide, particularly for stroke and metabolic syndrome components. The 2012 Ashwell meta-analysis of 300,000 participants found waist-to-height ratio superior to BMI for detecting diabetes, hypertension, dyslipidaemia, and cardiovascular disease, with AUCs of 0.68-0.74 versus 0.60-0.66.
BMI Stroke Risk Association: Weaker and Less Independent
The relationship between BMI and stroke is weaker than the link with coronary heart disease. The Global BMI Mortality Collaboration reported a hazard ratio of 1.12 per 5 kg/m² increase in BMI for stroke, compared with 1.27 for coronary heart disease. After adjustment for blood pressure, the dominant risk factor for stroke, the residual relationship is minimal. Blood pressure mediates a larger share of the BMI-stroke pathway than it does for coronary heart disease.
To understand stroke risk, prioritise blood pressure measurement over BMI. A high BMI with normal blood pressure carries far less stroke risk than a normal BMI with elevated blood pressure. Weight loss that reduces blood pressure does reduce stroke risk. Weight loss that does not change blood pressure has a much smaller effect.
Central Adiposity Heart Disease: Why Location Matters More Than Total Mass
Central adiposity, the accumulation of fat in the abdomen rather than subcutaneously, is independently linked to cardiovascular disease through its strong correlation with visceral adipose tissue. Visceral fat is metabolically active. It releases free fatty acids and inflammatory cytokines that directly affect insulin resistance, lipid metabolism, and vascular function. Waist circumference and waist-to-height ratio capture this risk. BMI does not.
The 2011 Emerging Risk Factors Collaboration found that waist-to-hip ratio had a stronger relationship with cardiovascular events than BMI, hazard ratio 1.32 per one-standard-deviation increase, versus 1.07 for BMI. Even after adjustment for blood pressure, lipids, and diabetes, waist-to-hip ratio retained some independent predictive power, particularly in older adults. This is the evidence base for NICE CG189's recommendation to use waist-to-height ratio as part of routine cardiovascular risk assessment.
If you measure one anthropometric variable for cardiovascular risk, measure waist circumference and calculate waist-to-height ratio. It outperforms BMI for every major cardiometabolic outcome. The 0.5 threshold is a population heuristic, not a personalised risk score. It is the single most useful screening signal available from a tape measure.
The Honest Caveat About BMI and Cardiovascular Risk
The single thing that most often goes wrong when interpreting BMI and cardiovascular risk is conflating association with causation. BMI is a statistical marker, not a causal agent. The weight on the scale does not damage arteries. The metabolic environment that tends to accompany weight gain does the damage: elevated blood pressure, disturbed lipid profile, insulin resistance. When clinicians control for those directly measured variables, the independent contribution of BMI shrinks to near zero for coronary heart disease and stroke. BMI remains useful as a screening tool for populations. For individual risk assessment, the direct measurements of blood pressure and lipid profile are what matter. A page that treats BMI as a cardiovascular diagnosis rather than a population screening signal has misled its reader from the first paragraph.
Common Questions
If BMI does not improve risk prediction once blood pressure and lipids are known, why do doctors still use it?
BMI is a fast, zero-cost screening tool that flags populations at higher average risk. It identifies people who are more likely to have elevated blood pressure and dyslipidaemia, even if it does not add independent predictive value once those are measured directly. It is a first-pass signal, not a final assessment.
Does waist-to-height ratio replace BMI entirely for cardiovascular risk?
No. NICE CG189 recommends using both. Waist-to-height ratio captures central adiposity risk that BMI misses, but BMI remains the standard for tracking population weight trends and for historical comparability. Use both for a fuller picture, but rely more on waist-to-height ratio for cardiometabolic risk screening.
Can a person with a normal BMI have high cardiovascular risk?
Yes. Normal-weight obesity, a normal BMI with excess body fat by body fat percentage or high waist circumference, carries elevated cardiovascular risk. A waist-to-height ratio above 0.5 in a normal-BMI individual signals central adiposity and increased risk that BMI alone would miss.
Does the obesity paradox mean a high BMI is protective for heart disease?
No. The obesity paradox is an observational finding in specific disease cohorts, confounded by reverse causation. Illness causes weight loss, making the heavier group appear healthier. Mendelian randomisation studies suggest the causal effect of higher adiposity on mortality is more linear than the observed J-curve implies.
